Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neurotrophin-3 (NT-3) is a protein growth factor and neurotrophic factor that plays a critical role in the development, maintenance, and function of the nervous system. It belongs to the nerve growth factor (NGF) family of neurotrophins and is essential for neuronal survival, differentiation, and synaptic plasticity. NT-3 primarily binds with high affinity to tropomyosin receptor kinase C (TrkC), a receptor tyrosine kinase. It can also activate TrkB but with lower affinity. Additionally, it interacts with p75NTR—a low-affinity pan-neurotrophin receptor. NT-3 has been shown to promote angiogenesis. Therapeutically, it is explored for promoting nerve regeneration after injury and investigated for ischemic disease due to proangiogenic effects. It is also targeted by small-molecule inhibitors/modulators aimed at TRK family kinases due to their involvement in cancer when aberrantly activated/fused (NTRK fusions).
Small-molecule inhibitors/modulators aimed at TRK family kinases
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurotrophin-3 (NT-3).